Purpose: The aim of this study was to evaluate neuron specific enolase (NSE) as prognostic factor for CNS disorders developed in relation to cardiac surgery. Patients and methods: A cohort of 92 patients were divided into two groups; the experimental group consisted of patients undergoing openheart bypass surgery (50 patients) and the control group consisting of 42 patients undergoing general surgery procedures. The blood levels of NSE were measured in both groups before and 24 h after the operation and have been related to the incidence of the postoperative brain damage as well as to the duration of the extracorporeal circulation (ECC). Results: The analysis of our results showed that the changes of blood NSE levels, before and immediately after ECC in open-heart surgery have been related to the incidence of postoperative brain dysfunction according to a specific mathematical equation. This incidence was raised also in relation to the age of the patient and the duration of ECC. On the contrary, NSE seems to have no prognostic value in general surgery.
INTRODUCTION
Enolase (2-phospho-D-glycerate hydrolase) is a glycolytic enzyme expressed by several isoenzymatic dimmers (␣␣, ␣␤, ␣␥, ␤␤, ␥␥) composed of three distinct subunits (␣, ␤, ␥). It was first described by Moore and McGregor in 1965 . The ␣-subunit is widely distributed in mammalian tissues and glial cells of the brain, while the ␤-subunit is localised primarily in the skeletal muscle and the myocardial tissue. Three different isoenzymes have been found in human brain: ␣␣, ␣␥ and ␥␥, with a molecular weight of approximately 80,000 daltons each. The ␣␥ and ␥␥ isoforms are known as neuron specific enolase (NSE) because they initially were found in neurons and neuroendocrine cells. The ␣␣-isoenzyme is also a dimmer and was designated as non-neuronal enolase. There are distinguished differences in biochemical properties between these two isoforms from brain tissue; most important of these differences is apparently the complete lack of immunological cross reactivity, which has been used for the quantification of NSE by several immunoassays. NSE's isoelectric point is 4.7 and is characterised by chloride, urea and temperature stability. It is assumed that NSE, being an enzyme from the cellular cytoplasm, is released during cell destruction. Thus, its presence in the circulation is related to a high death rate of cells with neuroendocrine differentiation, a characteristic of tumours producing the enzyme [Zomzely-Neurath, 1983] . This specific identification of NSE in blood has been extensively used to detect small cell lung cancer, neuroblastoma [Massaron et al, 1998; Zeltzer et al, 1986] , neuroendocrine tumours [Ishguro et al, 1983] , Creutzfeldt-Jacob disease [Zerri et al, 1995] , malignant melanoma [Lorenz et al, 1989] , seminoma [Fossa et al, 1992] , Merkel cell carcinoma [Chang et al, 1998 ], medulloblastoma [Zeltzer et al, 1986] , retinoblastoma [Ke Ping et al, 1995] and Guillain Barre syndrome [Mokuno et al, 1992] . According to Kirino et al, NSE seems to be a marker of neuronal regeneration [Kirino et al, 1983] .
NSE is also released from the brain to cerebrospinal fluid (CSF), as a result of an acute brain injury. Brain damage in patients undergoing open-heart surgery can result from brain ischaemia due to emboli (either air or thrombus) sent to the brain circulation through the ECC pump [McKibbin et al, 1976] . Embolic events caused by little pieces of plastic have been frequently reported in the past but currently, air, platelets thrombus and ECC agents are now considered as the commonest embolisation factors [Pearson et al, 1984] . It seems that the reduction of body temperature during ECC and the administration of barbiturates minimises the brain requirements for oxygen and protects it from the ischaemia that the emboli may cause [Steen et al, 1983] . Other drugs such as Ca ϩϩ blockers, 2-chloroadenosine [Evans et al, 1987] and phenytoin [Artru and Michenfelder, 1980] have also been used to reduce the incidence of postoperative brain damage following open-heart surgery. Among this neuroprotection process, it is very important to be able to identify in advance the patients in high-risk to develop brain dysfunction postoperatively. A large number of different agents and biomarkers have been occasionally used for the prognosis of postoperative brain damage during cardiac surgery. The S100 protein [Sellman et al, 1992] , AK [Aberg et al, 1984] , CK-BB [Taylor et al, 1980] are some of them used with moderate results.
METHODS
Our double blind study was based on a database of 100 patients admitted in two different departments; 50 of them in a Cardiac Surgery Department scheduled for open-heart surgery and 50 in a General Surgery Department for general surgery procedures respectively. The study protocol has been approved by the University's Scientific Ethics Committee. All patients were able to communicate with the investigators before the operation and an informed consent has been obtained in all cases. All of them had a previously unremarkable neurological and medical history upon their admission. The study was designed to measure and compare the level of NSE variance in the body serum of the patients before and after their scheduled operation. Thus, this patient population has been divided in two groups: The first group (group A), composed of 50 patients undergoing cardiac surgery because of coronary heart disease, and the second group (group B), composed of 50 patients also undergoing general surgery procedures. Among these two groups, we studied the correlation between the variance of the levels of NSE and the incidence of postoperative brain damage measured by the Hasegawa scale.
In order to measure NSE, we collected four blood samples (3 mL) at the following periods:
Group A: -Sample 1: 24 h before the induction to anaesthesia -Sample 2: before the entrance in the ECC -Sample 3: immediately after the ECC -Sample 4: 24 h after the operation.
Group B: -Sample 1: 24 h before the induction to anaesthesia -Sample 2: in the middle of the operation -Sample 3: at the end of the operation -Sample 4: 24 h after the operation.
The above blood samples were immediately centrifuged and the serum was frozen at Ϫ70°C and stored for later NSE analysis, using a commercially available immunoradiometric assay kit. The anaesthetic drug protocol in both groups included the following agents: midazolam, vekouronioum, fentanyl, propofol and isoforenium, in doses depended on the body weight of the patients.
RESULTS
The final study included 92 patients (33 men and 59 women). 42 of them had undergone general surgery and 50 cardiac surgery. Eight patients were excluded from the study either because one of the blood samples was inappropriate or because the patient was unable or unwilling to be evaluated with the Hasegawa score postoperatively. The mean age was 61.7 Ϯ 11.6 years (mean Ϯ sd) and the time of stress period was 67 Ϯ 53.7 min. The large standard deviation was due to the large sample range. The smallest recorded value was 2 min and the largest 314 min. For each case, the level of NSE has been recorded four times. The first NSE level recorded 24 h before surgery, the second level just before surgery, the third immediately after surgery and the fourth 24 h following surgery. The mental ability of each patient, as we have already mentioned, was evaluated using the Hasegawa score, having the lowest and highest score recorded as 0 and 38 respectively and a mean value of 27.95 Ϯ 11. 38. According to the results of our study, we have created the following algorithm:
3.738 ϫ sample 3 Ϫ 4.221 ϫ sample 2 Ͼ 6.767
If the above equation is fulfilled there is a very high possibility for postoperative brain dysfunction.
Statistical analysis
The normality assumption of the Hasegawa score distribution was tested with the use of the KolmogorofSmirnof test. Various nonparametric tests such as MannWhitney U-test, and Friedman's test were used, depending on the number of distributions tested. All the tests were at the level of significance a ϭ 0.05. The p-value of the Kolmogorof-Smirnof test is p ϭ 0.000 which rejects the null hypothesis of Normality of the Hasegawa score. Using the above Hasegawa dementia scale, patients' population has been classified into four categories according to their mental stage (Table 1) .
Friedman's test has been used for the testing of the equality of the distributions of the four NSE measurements. The power of the test is p ϭ 0.000, which means that the four distributions are not the same. The power of the Friedman test for the four NSE measurements within each of the four categories A, B, C, D, are 0.00, 0.00, 0.034, 0.37 respectively (Tables 2 and 3 ). It becomes obvious that the more severe the brain damage the stronger we reject the equality of the distributions. For the category D, where no brain dysfunction noted, the equality of the four distributions can not be rejected. Mean Hasegawa score for men and women is 25.61 Ϯ 7.61 and 32.12 Ϯ 6.8 respectively. The p-value for the U-test is p ϭ 0.012. The latter means that female patients take systematically higher score compared to the male ones. Spearman correlation coefficients between the age and the four NSE measurements were low, between 0.26 and 0.29. In terms of the type of surgery, it was mentioned that the patients under general surgery developed almost no brain dysfunction. It has been observed that 75% of the patients under general surgery did not develop any brain damage. A percentage of 25% of them are at the limited stage (C).
Then, we have grouped the four categories into two groups. The first group (group I) includes the categories A, B, C, in which the patients have developed brain dysfunction, while the second group (group II) includes the category D, i.e. the patients who did not develop any type of brain dysfunction. The statistical features of the two groups are summarised in Table 4 . It is obvious at the above table that the mean NSE level is the same in all four samples. The summary of the logistic regression is also presented in Table 5 . The p-value of the Friedman's test is p ϭ 0.31, which does not reject the equality of the distributions. The same does not hold for Group B of the sick patients. The same test rejects the equality of the distributions of the four NSE measurements (p ϭ 0.000) (Fig. 1) . In a graphic representation of this prognostic model (Fig. 2) , patients at risk to develop brain ischaemia during cardiac surgery are distributed in the area above the line, while patients distributed in the area below the line are in significantly less risk to develop postoperative brain dysfunction. An attempt has been also made to construct a more convenient model by replacing the NSE levels by the time of stress period; however the result of this attempt was rather poor as the percentage of correct prediction was only 50% and consequently, it was abandoned. 
DISCUSSION
The aim of our study was to correlate the NSE blood serum levels during and immediately after surgery with the incidence of the postoperative brain damage, in patients undergoing general and open-heart surgery. Our hypothesis was that NSE is released as a result of brain tissue destruction. There are previously published studies proposing the detection of the NSE isoenzyme in CSF, as the preferable method in terms of diagnostic accuracy. However, there are several limitations regarding the use of this method. A number of technical problems, such as the patient position or the multiple punctures of the dura mater necessary to obtain a series of samples in different times, make an attempt to take CSF samples during the operation difficult or even impossible. Thus, all the available published series using the above method, detect the NSE levels in CSF after the end of the operation; however, in this situation, the most crucial samples during the operation are lost. Alternatively, some authors recommend the detection of the NSE levels in blood serum as an accurate and effective method for the prognosis of the postoperative brain dysfunction [Roine et al, 1989] .
A review of the published literature reveals a significant variance in the conclusions concerning the relationship between the NSE levels and the postoperative brain dysfunction.
Johnsson et al [1995, 1996] found high NSE levels in cardiosurgical patients but not critical neurological outcome in the postoperative period. Sellman et al [1992] found no relationship between high NSE levels and postoperative brain damage. Isgro et al [1997] , suggested that high NSE levels after open-heart surgery are followed by brain damage installation and Hardemark et al in 1988 and , found a quantitative relationship between the NSE levels and the severity of the postoperative brain damage [Hardemark et al, 1988 [Hardemark et al, , 1989 .
According to older studies [Frank et al, 1972 ] the incidence of the postoperative neurological complications following cardiac surgery can be described by a 0-100% scale. In most recent publications, Adrian et al [1995] , found neurological complications ranging from 1 to 57%. In our study, the incidence of neurological complications was 44% for the open-heart surgery group and not significant for the general surgery group. The serum NSE levels among the four different blood samples were found the same in the general surgery group, but this was not the case in the open-heart surgery group (p-values: 0.612 and 0.000, median Hasegawa score: 33.6 Ϯ 2.72 and 23.14 Ϯ 13.51 respectively).
The current trend regarding open-heart procedures, is towards early mobilisation and shorter hospitalisation, especially concerning the postoperative period patients spend in the ICU. In the presented study, we have collected three different blood samples for each individual patient during the operation, as we have assessed this period as the most crucial in the prognosis of postoperative brain dysfunction. To further support this assessment, the highest NSE serum levels have been found during the ECC. Thus, by evaluating the NSE levels at the time 2 and 3 of the operation, it may be possible to identify the patients in high-risk for postoperative brain damage. Savageau et al [1982] , identified a positive relation between patient's age and postoperative brain damage. We have also found a similar correlation between these two parameters. Furthermore, sex was found another factor influencing brain dysfunction following cardiac surgery. Men in our study had a median Hasegawa score of 25.61 Ϯ 7.61, while the mean Hasegawa score for women was 32.12 Ϯ 6. NSE serum levels at the same time were lower for female than for male patients. These results indicate that women are expected to have better neurological outcome in the postoperative period, but this cannot be an absolute conclusion since the number of female patients in the open-heart surgery group was small.
Another relationship was also found between the duration of the ECC and the installation of postoperative brain dysfunction in our series. It is obvious that when the time of the ECC is prolonged, the possibility for the occurrence of events that may influence brain function becomes higher and this must be the most probable explanation for this correlation. Similar results and conclusions have been also presented in other published studies [Isgro et al, 1997; Sellman et al, 1992] .
A number of previously reported series [Aberg et al, 1984; Sellman et al, 1992; Zelter et al, 1986] , have examined the role of various other enzymes as indicators of the postoperative brain dysfunction is an intracellular enzyme that can be detected in the red blood cells as well as in CSF after cerebral ischaemia. The detection of high levels of AK has a positive correlation to brain dysfunction after ECC but the presence of AK in serum may be also the result of haemolysis and thus, a cause of false positive results. The detection of protein S100
2 [Sellman, 1992] may also be used as an indicator of the postoperative brain damage, but it is a more expensive and a less sensitive method. CK-BB [Taylor et al, 1980 ] is a predictive biochemical marker used by some investigators, but has not proved as reliable as NSE as it creates frequent cross-reactions to other isoenzymes. Eventually, it seems that the detection of blood serum NSE is the most accurate and reliable factor available for early prognosis of brain dysfunction following open-heart surgery .
CONCLUSION
The results of our double blind study shows that blood serum NSE levels, particularly immediately before and after the ECC, is a sensitive, inexpensive and safe method that may contribute significantly in the early prognosis of postoperative brain dysfunction. Further studies focusing on the predictive role of the NSE levels in different types of operations with a high incidence of perioperative brain ischaemia, such as thoracic aorta or brain aneurysms, will be necessary for evaluation of its efficacy as a prognostic factor in a wider range of performances.
